Chemical Component Summary

Name1-[(~{E})-(5-nitrofuran-2-yl)methylideneamino]imidazolidine-2,4-dione
SynonymsNitrofurantoin
Identifiers1-[(~{E})-(5-nitrofuran-2-yl)methylideneamino]imidazolidine-2,4-dione
FormulaC8 H6 N4 O5
Molecular Weight238.157
TypeNON-POLYMER
Isomeric SMILESc1cc(oc1/C=N/N2CC(=O)NC2=O)N(=O)=O
InChIInChI=1S/C8H6N4O5/c13-6-4-11(8(14)10-6)9-3-5-1-2-7(17-5)12(15)16/h1-3H,4H2,(H,10,13,14)/b9-3+
InChIKeyNXFQHRVNIOXGAQ-YCRREMRBSA-N

Chemical Details

Formal Charge0
Atom Count23
Chiral Atom Count0
Bond Count24
Aromatic Bond Count5

Drug Info: DrugBank

DrugBank IDDB00698 
NameNitrofurantoin
Groups
  • vet_approved
  • approved
DescriptionNitrofurantoin is a nitrofuran antibiotic used to treat uncomplicated urinary tract infections.[L6856,L6859,L6862] Nitrofurantoin is converted by bacterial nitroreductases to electrophilic intermediates which inhibit the citric acid cycle as well as synthesis of DNA, RNA, and protein.[A179824] This drug is more resistant to the development of bacterial resistance because it acts on many targets at once.[A179824] Nitrofurantoin is a second line treatment to [trimethoprim]/[sulfamethoxazole].[A179830] Nitrofurantoin was granted FDA approval on 6 February 1953.[L6895]
Synonyms
  • nitrofurantoine
  • Nitrofurantoin sodium
  • Nitrofurantoin monohydrate
  • Nitrofurantoin, macrocrystals
  • nitrofurantoinum
Brand Names
  • Nitrofurantoin Monohydrate/Macrocrystal
  • Jamp Nitrofurantoin
  • Nitrofurantoin macrocrystals
  • PMS-nitrofurantoin Bid
  • Teva-nitrofurantoin
IndicationNitrofurantoin is indicated to treat acute uncomplicated urinary tract infections.[L6856,L6859,L6862]
Categories
  • Agents causing hyperkalemia
  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Anti-Infective Agents, Urinary
  • Antibacterials for Systemic Use
ATC-Code
  • J01XE01
  • J01XE51
CAS number67-20-9

Drug Targets

NameTarget SequencePharmacological ActionActions
Probable pyruvate-flavodoxin oxidoreductaseMITIDGNGAVASVAFRTSEVIAIYPITPSSTMAEQADAWAGNGLKNVWGD...unknownpotentiator
Oxygen-insensitive NADPH nitroreductaseMTPTIELICGHRSIRHFTDEPISEAQREAIINSARATSSSSFLQCSSIIR...unknownpotentiator
30S ribosomal protein S10MQNQRIRIRLKAFDHRLIDQATAEIVETAKRTGAQVRGPIPLPTRKERFT...unknowninhibitor
NADPH--cytochrome P450 reductaseMGDSHVDTSSTVSEAVAEEVSLFSMTDMILFSLIVGLLTYWFLFRKKKEE...unknownsubstrate
ATP-binding cassette sub-family G member 2MSSSNVEVFIPVSQGNTNGFPATASNDLKAFTEGAVLSFHNICYRVKLKS...unknownsubstrate
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL572
PubChem 6604200
ChEMBL CHEMBL572
ChEBI CHEBI:71415, CHEBI:95222